report solid result share gain fuel solid
organ sale growth slight fy ep guidanc rais
difficult industri environ ep cent cent
consensu driven profit beat revenu consensu
organ sale strong difficult environ well
consensu market expect chd guidanc although
gross margin came bp consensu driven bp headwind
voluntari recal orajel oral care product drive modest
gross profit upsid lower sg off-set gross margin pressur
lower ad spend vs model drive oper profit upsid versu
consensu top-line perform remain strong
growth estim comment call guidanc incorpor flat
slightli posit price domest consum segment lap
discount compar period promot eas categori
within laundri sound comfort categori
dynam competit concentr tide persil
high end continu well valu segment point
oner top-line comparison press potenti
conservat embed guidanc although waterpik acquisit
enter organ sale base august estim waterpik hsd
consum domest busi grow hsd worth bp
consum domest organ sale growth fulli base
ep guidanc rais end rais ep guidanc
modestli low end vs prior in-lin
consensu mse report sale expect exceed vs
prior organ sale vs exceed prior expect
gross margin declin bp vs bp last quarter reflect higher
logist cost voluntari recal fda mandat withdraw
market sale expect recent acquisit
lower market spend rate regard guid organ sale
household person unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
growth report sale growth ep includ higher
market consensu mse although
tend conserv next quarter guidanc call
lower tax guidanc prior worth ep net
post ep estim rise cent slightli
guidanc ep cent increas
price target prior reflect ep upsid impli
ev/ebitda versu prior remain uw post solid believ solid
execut reflect ntm price-to-earnings premium vs hpc
peer particularli given difficult industri environ well limit
deriv base case scenario
topline/gross margin upsid rebound laundri result drive bp
top-line upsid cost effici weaker expect commod inflat
drive increment basi point gross margin upsid strateg
halo increas appli multipl deviat last averag
bull case ep
slow organ growth deliv average org sale growth
in-lin long-term target appli price-to-earnings
base case ep line last averag given slowdown
secular us slowdown worsen revenu growth forecast
due competit price pressur us volum downsid spur
reinvest compress valuat bear case ep
slightli peak trough multipl compress food peer
believ us hpc industri pressur point
fragment limit price limit
result given skew us
consolid halo valuat
overdon main reason low
core sg compar peer leav less
room synergi busi
make difficult manag
premium peer limit roic/ep accret
excel manag team
alreadi manag busi well
like less interest mani potenti
acquir view
ep look high us
given limit growth limit strateg
risk achiev price
product higher expect potenti
accret acquisit consolid
us promot intens key
categori ramp us volum downsid
commod inflat execut risk
exhibit bear bull us environ risk laundri upsid
inform opinion research prepar co llc and/or and/or morgan
stanley mexico de bolsa de and/or canada limit use disclosur section includ morgan
stanley co llc mexico de bolsa de canada limit affili
necessari
import disclosur stock price chart equiti rate histori regard compani subject report pleas see morgan
stanley research disclosur websit www morganstanley com/researchdisclosur contact invest repres
research broadway attent research manag new york ny usa
valuat methodolog risk associ recommend rate price target referenc research report pleas contact client
support follow us/canada hong kong latin america london
singapor sydney tokyo altern may contact invest repres morgan
stanley research broadway attent research manag new york ny usa
follow analyst herebi certifi view compani secur discuss report accur express
receiv receiv direct indirect compens exchang express specif recommend view report dara
unless otherwis state individu list cover page report research analyst
morgan stanley research publish accord conflict manag polici avail
import us regulatori disclosur subject compani
